Hiroyuki Ohbayashi
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 15, 2021
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study.Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya
|Jun 24, 2021
Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study.Yoichi Nakamura, Soichiro Hozawa, Hironori Sagara
|Mar 02, 2021
Comparison of User Satisfaction and Preference with Inhalant Devices Between a Pressurized Metered-Dose Inhaler and Ellipta in Stable Asthma Patients: A Randomized, Crossover Study.Hiroyuki Ohbayashi, Takamitsu Asano, Sahori Kudo
|Feb 07, 2020
Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial.Hiroyuki Ohbayashi, Sahori Kudo, Mitsue Ariga
Pageof 1
